BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9056869)

  • 1. Structure, function and biogenesis of the mycobacterial cell wall.
    Brennan PJ; Besra GS
    Biochem Soc Trans; 1997 Feb; 25(1):188-94. PubMed ID: 9056869
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-to-function relationship of mycobacterial cell envelope components.
    Takayama K; Datta AK
    Res Microbiol; 1991 May; 142(4):443-8. PubMed ID: 1871431
    [No Abstract]   [Full Text] [Related]  

  • 3. Structure, function and biogenesis of the cell envelope of mycobacteria in relation to bacterial physiology, pathogenesis and drug resistance; some thoughts and possibilities arising from recent structural information.
    McNeil MR; Brennan PJ
    Res Microbiol; 1991 May; 142(4):451-63. PubMed ID: 1871433
    [No Abstract]   [Full Text] [Related]  

  • 4. The mycobacterial cell wall: biosynthesis of arabinogalactan and lipoarabinomannan.
    Besra GS; Brennan PJ
    Biochem Soc Trans; 1997 Aug; 25(3):845-50. PubMed ID: 9388559
    [No Abstract]   [Full Text] [Related]  

  • 5. Biogenesis of the mycobacterial cell wall and the site of action of ethambutol.
    Mikusová K; Slayden RA; Besra GS; Brennan PJ
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2484-9. PubMed ID: 8585730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arabinogalactan and lipoarabinomannan biosynthesis: structure, biogenesis and their potential as drug targets.
    Jankute M; Grover S; Rana AK; Besra GS
    Future Microbiol; 2012 Jan; 7(1):129-47. PubMed ID: 22191451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical Genetic Interaction Profiling Reveals Determinants of Intrinsic Antibiotic Resistance in Mycobacterium tuberculosis.
    Xu W; DeJesus MA; Rücker N; Engelhart CA; Wright MG; Healy C; Lin K; Wang R; Park SW; Ioerger TR; Schnappinger D; Ehrt S
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mycobacterial cell wall: structure, biosynthesis and sites of drug action.
    Chatterjee D
    Curr Opin Chem Biol; 1997 Dec; 1(4):579-88. PubMed ID: 9667898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of 7-amino-4-methylcoumarin as an effective antitubercular agent: structure-activity relationships.
    Tandon R; Ponnan P; Aggarwal N; Pathak R; Baghel AS; Gupta G; Arya A; Nath M; Parmar VS; Raj HG; Prasad AK; Bose M
    J Antimicrob Chemother; 2011 Nov; 66(11):2543-55. PubMed ID: 21917615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethambutol, a cell wall inhibitor of Mycobacterium tuberculosis, elicits L-glutamate efflux of Corynebacterium glutamicum.
    Radmacher E; Stansen KC; Besra GS; Alderwick LJ; Maughan WN; Hollweg G; Sahm H; Wendisch VF; Eggeling L
    Microbiology (Reading); 2005 May; 151(Pt 5):1359-1368. PubMed ID: 15870446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assembly of the Mycobacterial Cell Wall.
    Jankute M; Cox JA; Harrison J; Besra GS
    Annu Rev Microbiol; 2015; 69():405-23. PubMed ID: 26488279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the formation of the cell wall core of M. tuberculosis.
    Barry CE; Crick DC; McNeil MR
    Infect Disord Drug Targets; 2007 Jun; 7(2):182-202. PubMed ID: 17970228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of the primary target for isoniazid in mycobacterial mycolic acid biosynthesis with Mycobacterium aurum A+.
    Wheeler PR; Anderson PM
    Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):451-7. PubMed ID: 8809032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structure and function of the isoniazid target in M. tuberculosis.
    Sacchettini JC; Blanchard JS
    Res Microbiol; 1996; 147(1-2):36-43. PubMed ID: 8761720
    [No Abstract]   [Full Text] [Related]  

  • 15. Ethambutol-sugar hybrids as potential inhibitors of mycobacterial cell-wall biosynthesis.
    Reynolds RC; Bansal N; Rose J; Friedrich J; Suling WJ; Maddry JA
    Carbohydr Res; 1999 Apr; 317(1-4):164-79. PubMed ID: 10466213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethambutol inhibition of glucose metabolism in mycobacteria: a possible target of the drug.
    Silve G; Valero-Guillen P; Quemard A; Dupont MA; Daffe M; Laneelle G
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1536-8. PubMed ID: 8363387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chapter 2: Biogenesis of the cell wall and other glycoconjugates of Mycobacterium tuberculosis.
    Kaur D; Guerin ME; Skovierová H; Brennan PJ; Jackson M
    Adv Appl Microbiol; 2009; 69():23-78. PubMed ID: 19729090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The composition of cell wall skeleton and outermost lipids of Mycobacterium vaccae is modified by ethambutol treatment.
    Rumijowska-Galewicz A; Korycka-Machała M; Lisowska K; Dziadek J
    Pol J Microbiol; 2008; 57(2):99-104. PubMed ID: 18646396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of isoniazid on mycolic acid synthesis in Mycobacterium tuberculosis and on its cell envelope.
    Winder FG; Collins P; Rooney SA
    Biochem J; 1970 Apr; 117(2):27P. PubMed ID: 4986870
    [No Abstract]   [Full Text] [Related]  

  • 20. IQG-607 abrogates the synthesis of mycolic acids and displays intracellular activity against Mycobacterium tuberculosis in infected macrophages.
    Rodrigues-Junior VS; dos Santos Junior AA; Villela AD; Belardinelli JM; Morbidoni HR; Basso LA; Campos MM; Santos DS
    Int J Antimicrob Agents; 2014 Jan; 43(1):82-5. PubMed ID: 24139881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.